Press "esc" to clear
Go to Advanced Search

Showing results

1120 of 2091
RS14572_GaneshHalade-3RT-scrlandscape.jpg

Article ID: 689868

Resolvin D-1 Limits Kidney Damage After Heart Attacks

University of Alabama at Birmingham

Lingering inflammation after heart attack can lead heart failure. It can also claim another victim — the kidneys. New research shows that a bioactive compound called resolvin D-1, injected as a therapeutic dose, is able to limit this collateral damage in the kidneys, as tested in an animal model.

Released:
20-Feb-2018 4:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cardiovascular Health, Heart Disease, Kidney Disease, Pharmaceuticals, All Journal News, Grant Funded News

Jaremko_Kellie.jpg

Article ID: 689725

Dr. Kellie M. Jaremko Named 2018 Resident/Fellow of the Year

American Society of Regional Anesthesia and Pain Medicine (ASRA)

Dr. Kellie Jaremko, MD, PhD, an anesthesiology resident at Massachusetts General Hospital in Boston, has been named ASRA’s 2018 Resident/Fellow of the Year.

Released:
16-Feb-2018 1:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Healthcare, Pharmaceuticals, Local - Pennsylvania

Article ID: 689573

A New Class of Drug to Treat Herpes Simplex Virus Infection

University of Illinois at Chicago

For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.If patients develop resistance to these drugs, there are even fewer choices left to treat the infection, which lasts for life.Researchers at the University of Illinois at Chicago have now identified a small drug molecule that can clear the HSV-1 infection in the cells of the cornea — the clear outer layer of the eyeball — and works completely differently than the currently-available drugs, making it a promising potential option for patients who have developed resistance.

Released:
14-Feb-2018 4:00 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Infectious Diseases, Public Health, Chemistry, Pharmaceuticals, Local - Illinois, All Journal News

Article ID: 689506

Heroin Vaccine Blocks Lethal Overdose

Scripps Research Institute

Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug.

Released:
13-Feb-2018 6:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Addiction, All Journal News, Drugs and Drug Abuse, Pharmaceuticals, Local - California, Grant Funded News

Lin-ATF6-activated-hES-BV.jpg
  • Embargo expired:
    13-Feb-2018 2:00 PM EST

Article ID: 689367

In Effort to Treat Rare Blinding Disease, Researchers Turn Stem Cells into Blood Vessels

University of California San Diego Health

People with a mutated ATF6 gene have a malformed or missing fovea, severely limiting vision. UC San Diego School of Medicine researchers first linked ATF6 to this type of vision impairment. Now the team discovered that a chemical that activates ATF6 converts patient stem cells into blood vessels.

Released:
12-Feb-2018 12:15 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cell Biology, Genetics, Pharmaceuticals, Stem Cells, Vision, Local - California, Grant Funded News

Article ID: 689456

Scientists Create Most Sophisticated Human Liver Model Yet

Wake Forest Baptist Medical Center

Scientists have developed the most sophisticated mini-livers to date. These organoids can potentially help scientists better understand certain congenital liver diseases as well as speed up efforts to create liver tissue in the lab for transplantation into patients.

Released:
13-Feb-2018 11:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Liver Disease, Pharmaceuticals

Article ID: 689432

On-Screen, On-Demand, On-Time: The Future of Telemedicine at Penn Medicine

Perelman School of Medicine at the University of Pennsylvania

Penn Medicine Announces its new Center for Connected Care to centralize the health system’s telemedicine activities.

Released:
13-Feb-2018 10:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Healthcare, Patient Safety, Pharmaceuticals, Local - Pennsylvania

Drugs.jpg

Article ID: 689436

WashU Expert: Budget Provides Insight Into Trump Administration Drug Policy

Washington University in St. Louis

During his first year in office, President Donald Trump spoke about high drug prices but took little action to address the problem. His budget proposal, released this week, does lay out a strategy — though what is most notable is not what’s included, but rather what is missing, said an expert on drug pricing and policy at Washington University in St.

Released:
13-Feb-2018 9:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Law and Public Policy

Channels:

Government/Law, Pharmaceuticals, U.S. Politics

robbin.JPG

Article ID: 689427

Light-Activated Cancer Drugs Without Toxic Side Effects: Fresh Insight

University of Warwick

Future cancer drugs that are activated by light and don’t cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research made possible by the Monash Warwick Alliance, an intercontinental collaboration between the University of Warwick (UK) and Monash University (Australia).

Released:
13-Feb-2018 8:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment
Rzcartoon.jpg
  • Embargo expired:
    12-Feb-2018 3:00 PM EST

Article ID: 689260

Mount Sinai Researchers Identify New Intracellular Pathway to Promote Pain Relief Without Increasing the Risk of Addiction

Mount Sinai Health System

Study results may provide mechanism to make opioids safer and more efficient

Released:
8-Feb-2018 2:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Addiction, Pain, Pharmaceuticals, Local - New York, Local - New York Metro, All Journal News, PNAS


Showing results

1120 of 2091





Chat now!